Patient´s cells to accelerate new drug discovery at CiMUS (Center for Research in Molecular Medicine and Chronic Diseases), Universidad de Santiago de Compostela. The first three Kaertor projects are high-risk programs with one year to be developed.
Photo: Mabel Loza and Ángel Carracedo (Xoan A. Soler).
Links of interest:
· The Janssen Pharmaceutical Companies of Johnson & Johnson
· GAIN Axencia Galega de Innovación
0 Comments
Leave A Comment